However, no significant difference was observed in the proportions of T (CD3+), B (CD19+) and NK (CD56+) fractions (Fig. S3C in the Supplementary material) or CD4+ and CD8+ T cell fractions (Fig. S3D in the Supplementary material) between HD-M and BC-M. This evidence concerns the gene CD4 and breast cancer.